(NASDAQ:LENZ),(TAI:1795.TW), SAN DIEGO and TAIPEI, Taiwan, Dec. 01, 2025 (GLOBE NEWSWIRE) — LENZ Therapeutics, Inc. (Nasdaq: LENZ) and Lotus Pharmaceutical Co., Ltd. (“Lotus”, TWSW Stock Code: 1795) today announced that Lotus has submitted a New Drug Application (NDA) to the Ministry of Food and Drug Safety (MFDS) for the review and approval of VIZZTM, for […]
(Other OTC:CYDY),(OTC US:CYDY), VANCOUVER, Washington, Dec. 01, 2025 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized monoclonal antibody targeting the CCR5 receptor with therapeutic potential across multiple indications, including metastatic triple-negative breast cancer (mTNBC) and colorectal cancer (mCRC), today announced that it has
(NASDAQ:HDSN), WOODCLIFF LAKE, N.J., Dec. 01, 2025 (GLOBE NEWSWIRE) — Hudson Technologies, Inc. (NASDAQ: HDSN) announced that its board of directors has approved an increase to the Company's share repurchase authorization. Hudson may now purchase up to $20 million in shares of its common stock during calendar year 2025, an increase from up to $10
(NASDAQ:DFDV), BOCA RATON, FL, Dec. 01, 2025 (GLOBE NEWSWIRE) — DeFi Development Corp. (Nasdaq: DFDV) (the “Company”), the first public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced it has begun integrating and running the open block-building infrastructure provided by Harmonic across its Solana validator operations. Harmonic introduces competition
(NASDAQ:BDRX), December 1, 2025 Biodexa Announces Enrolment of First European Patients into Pivotal Phase 3 Serenta Trial in FAP Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, is pleased to announce the enrolment of
The Oncology Institute Announces Resignation of Board Member Gabe Ling GlobeNewswire December 01, 2025 CERRITOS, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) — The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Gabe Ling has resigned from the Board of Directors, effective December 1,
Mixie Technologies, Inc. (OTC: PHCG) formerly known as Pure Harvest Corporate Group, Executes Binding Letter of Intent to Acquire Minority Interest in HoloTwin LLC Introduces AI-driven digital twin visualization capabilities aligned with Mixie's evolution into a technology and platform focused enterprise GlobeNewswire December 01, 2025 DENVER, Dec. 01, 2025 (GLOBE NEWSWIRE) — Mixie Technologies, Inc.
Recursion Announces Webinar For Upcoming Clinical Data Readout on the TUPELO Phase 1b/2 Trial of REC-4881 in Familial Adenomatous Polyposis on December 8, 2025 GlobeNewswire December 01, 2025 Salt Lake City, Dec. 01, 2025 (GLOBE NEWSWIRE) — Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, announced today that
Rush Street Interactive Named Operator of the Year-North LatAm at the EGR LatAm Awards GlobeNewswire December 01, 2025 CHICAGO, Dec. 01, 2025 (GLOBE NEWSWIRE) — Rush Street Interactive, Inc. (NYSE: RSI) (“RSI”), a leading online casino and sports betting company in the United States and the rest of the Americas, is proud to announce that
Brian Lanktree to Join Raven Capital as Senior Managing Director and Head of Capital Solutions GlobeNewswire December 01, 2025 LOS ANGELES, Dec. 01, 2025 (GLOBE NEWSWIRE) — Raven Capital (“Raven”), an alternative investment firm specializing in asset-based, non-sponsor private credit, today announced that Brian Lanktree has been named Senior Managing Director and Head of Capital